Lilly, Novo Nordisk Under Government Investigation For Promotion Of Their Diabetes Drugs

The Attorney General of Texas is looking into Lilly's marketing of Actos while the Massachusetts U.S. Attorney's Office is investigating Novo's promotion of NovoLog, Levemir and Victoza.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet